Travaux scientifiques

Prof. Dr. Abdullah Sakin

247 publications. La source de l’information est indiquée à côté de chaque publication.

Retour au profil

  1. Impact of systemic inflammatory markers in patients with ALK -positive non-small cell lung cancer treated with crizotinib

    Pulmonology, 2022

    DOI 10.1016/j.pulmoe.2022.11.006 PMID 36564237 13 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  2. Prognostic factors of perioperative FLOT regimen in operable gastric and gastroesophageal junction tumors: real-life data (Turkish Oncology Group)

    TURKISH JOURNAL OF MEDICAL SCIENCES, 2022

    DOI 10.55730/1300-0144.5404 PMID 36326360 6 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  3. The prognostic effect of pretreatment 18F-FDG PET/CT metabolic parameters in locally advanced Esophageal Squamous Cell Carcinoma treated with definitive chemoradiotherapy

    Surgical Oncology, 2022

    DOI 10.1016/j.suronc.2022.101809 PMID 35809492 8 citations (Europe PMC) Source : OpenAlex

  4. Efficacy and safety of folfiri plus aflibercept in second-line treatment of metastatic colorectal cancer

    Journal of Cancer Research and Therapeutics, 2022

    DOI 10.4103/jcrt.jcrt_1104_21 PMID 36510987 6 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  5. Effect of Adjuvant Chemotherapy in Stage III Cervical Cancer Patients Treated with Concurrent Chemoradiation: A Multicenter Study

    Oncology Research and Treatment, 2022

    DOI 10.1159/000521980 PMID 35034017 3 citations (Europe PMC) Source : OpenAlex

  6. The percentage of ALK-positive cells and the efficacy of first-line alectinib in advanced non-small cell lung cancer: is it a novel factor for stratification? (Turkish Oncology Group Study)

    Journal of Cancer Research and Clinical Oncology, 2022

    DOI 10.1007/s00432-022-04252-2 PMID 36048274 5 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  7. Real-world data on efficacy and safety of first-line alectinib treatment in advanced-stage, ALK-positive non-small-cell lung cancer patients: a Turkish Oncology Group study

    Future Oncology, 2022

    DOI 10.2217/fon-2022-0083 PMID 35734870 3 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  8. Real life experience of patients with locally advanced gastric and gastroesophageal junction adenocarcinoma treated with neoadjuvant chemotherapy: a Turkish oncology group study

    Journal of Chemotherapy, 2022

    DOI 10.1080/1120009x.2022.2073159 PMID 35579894 1 citation (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  9. Factors affecting survival in operated gastric cancer

    Surgical Oncology, 2022

    DOI 10.1016/j.suronc.2022.101887 PMID 36455334 3 citations (Europe PMC) Source : OpenAlex

  10. Pazopanib in metastatic soft tissue sarcoma (STS): Results of a multi-institutional observational study.

    Journal of Clinical Oncology, 2022

    DOI 10.1200/jco.2022.40.16_suppl.e23542 2 citations (OpenAlex) Source : OpenAlex

  11. P-92 Real-life experience with maintenance chemotherapy plus biologics after the first-line treatment of RAS wild-type metastatic colon cancer (mCRC): A multicenter Onco-Colon Turkey study

    Annals of Oncology, 2022

    DOI 10.1016/j.annonc.2022.04.182 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  12. The impact of adjuvant oxaliplatin and tumor sidedness on the overall survival of stage IIB colon cancer patients: a multicentre study

    Journal of Chemotherapy, 2022

    DOI 10.1080/1120009x.2022.2040770 PMID 35174772 Texte intégral en libre accèsSource : OpenAlex

  13. Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC.

    Journal of Clinical Oncology, 2022

    DOI 10.1200/jco.2022.40.16_suppl.e15562 Source : OpenAlex

  14. Predictive Factors of Complete Tumor Response to First Line Chemotherapy in Patients with Extensive-stage Small Cell Lung Cancer

    Bagcilar Medical Bulletin, 2022

    DOI 10.4274/bmb.galenos.2022.2021-09-098 Texte intégral en libre accèsSource : OpenAlex

  15. P-90 First-line anti-EGFR agents (panitumumab or cetuximab) plus chemotherapy in patients with metastatic colorectal cancer: Onco-colon Turkey study subgroup analysis

    Annals of Oncology, 2022

    DOI 10.1016/j.annonc.2022.04.180 Texte intégral en libre accèsSource : OpenAlex

  16. Efficacy of Imatinib on Advanced and Refractory Desmoid Tumors: A Retrospective Study

    Journal of Oncological Sciences, 2022

    DOI 10.37047/jos.2021-87391 Texte intégral en libre accèsSource : OpenAlex

  17. Pazopanib in metastatic soft tissue sarcoma (STS): Results of a multi-institutional observational study.

    Bursa Uludag University - AVESIS, 2022

    Source : OpenAlex

  18. Clinical and Pathological Characteristics of Patients with High-Risk Breast Cancer Based on BRCA Mutation Profiles: A Retrospective Study

    European Journal of Breast Health, 2021

    DOI 10.4274/ejbh.galenos.2020.6346 PMID 33870111 11 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  19. The Predictive Value of Baseline Volumetric PET/CT Parameters on Treatment Response and Prognosis in Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy

    Journal of Gastrointestinal Cancer, 2021

    DOI 10.1007/s12029-021-00608-y PMID 33651265 11 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  20. Trastuzumab ± Capecitabine Maintenance After the First-Line Treatment of HER2-Positive Advanced Gastric Cancer: Retrospective Observational Real-Life Data of Turkish Oncology Group

    Journal of Gastrointestinal Cancer, 2021

    DOI 10.1007/s12029-021-00594-1 PMID 33538958 4 citations (Europe PMC) Source : OpenAlex

  21. Survival and Prognostic Factors in Limited-stage Small-cell Lung Cancer

    Journal of College of Physicians And Surgeons Pakistan, 2021

    DOI 10.29271/jcpsp.2021.12.1433 PMID 34794283 7 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  22. The Prognostic Value of Postoperative Lymph Node Ratio in Gastric Adenocarcinoma Patients Treated With Neoadjuvant Chemotherapy

    Cureus, 2021

    DOI 10.7759/cureus.14639 PMID 34046274 5 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  23. Chemoradiotherapy followed by surgery versus observation in esophageal squamous cell carcinoma.

    PubMed, 2021

    PMID 34565012 4 citations (Europe PMC) Source : OpenAlex

  24. Multiple Primary Synchronous Gastric, Esophageal, and Rectal Cancer and Isolated Esophageal Metastasis from Rectal Cancer: Case Report

    Journal of Oncological Sciences, 2021

    DOI 10.37047/jos.2020-80507 Source : OpenAlex

  25. 124P Talazoparib in locally advanced or metastatic breast cancer patients: Experience from an early access program in Turkey

    Annals of Oncology, 2021

    DOI 10.1016/j.annonc.2021.03.138 2 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  26. Factors affecting survival in retroperitoneal sarcomas treated with upfront surgery: A real-world study by Turkish Oncology Group

    Van Yüzüncü Yıl University Academic Data Management System, 2021

    DOI 10.4999/uhod.215190 2 citations (OpenAlex) Source : OpenAlex

  27. Real-Life Analysis of Efficacy and Safety of Everolimus Plus Exemestane in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Metastatic Breast Cancer Patients: A Turkish Oncology Group (TOG) Study

    Cancer Investigation, 2021

    DOI 10.1080/07357907.2021.2017952 PMID 34894960 3 citations (Europe PMC) Source : OpenAlex

  28. Factors Affecting Survival in Operated Esophageal Squamous Cell Carcinoma

    Journal of Gastrointestinal Cancer, 2021

    DOI 10.1007/s12029-021-00631-z PMID 33788157 2 citations (Europe PMC) Source : OpenAlex

  29. Effect of type 2 diabetes mellitus on survival in metastatic pancreatic cancer

    Journal of Surgery and Medicine, 2021

    DOI 10.28982/josam.840948 2 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  30. Efficacy and Tolerability of Current Treatments for Hormone-Refractory Prostate Cancer Patients with Visceral Metastases

    Future Oncology, 2021

    DOI 10.2217/fon-2020-1032 PMID 33631986 Source : OpenAlex

  31. P-219 Real-life experience with chemotherapy plus biologics in first-line treatment of right-sided, RAS wild-type, metastatic colon cancer: A multicenter Onco-Colon Turkey study

    Annals of Oncology, 2021

    DOI 10.1016/j.annonc.2021.05.273 Texte intégral en libre accèsSource : OpenAlex

  32. Küçük Molekül Tirozin Kinaz İnhibitörleri; MET Hedefli Tedaviler (Capmatinib)

    Turkiye Klinikleri Medical Oncology - Special Topics, 2021

    Source : OpenAlex

  33. 1405P Efficacy and safety of perioperative FLOT (5-FU, LV, oxaliplatin, docetaxel) chemotherapy in gastric and gastroesophageal junction adenocarcinoma: Real-life data from Turkish oncology group

    Annals of Oncology, 2021

    DOI 10.1016/j.annonc.2021.08.1514 Texte intégral en libre accèsSource : OpenAlex

  34. Is lymph node dissection necessary for staging while undergoing nephrectomy in patients with renal cell carcinoma?

    Current Problems in Cancer, 2020

    DOI 10.1016/j.currproblcancer.2020.100619 PMID 32800688 5 citations (Europe PMC) Source : OpenAlex

  35. Mean platelet volume and platelet distribution width correlates with prognosis of early colon cancer.

    PubMed, 2020

    PMID 32277636 13 citations (Europe PMC) Source : OpenAlex

  36. The Clinical Importance of Androgen Receptor Status in Response to Neoadjuvant Chemotherapy in Turkish Patients with Local and Locally Advanced Breast Cancer

    Oncology Research and Treatment, 2020

    DOI 10.1159/000508478 PMID 32570261 11 citations (Europe PMC) Source : OpenAlex

  37. Assessment of pretreatment albumin-bilirubin grade in pancreatic cancer patients with liver metastasis.

    PubMed, 2020

    PMID 33099936 10 citations (Europe PMC) Source : OpenAlex

  38. The impact of tumor regression grade on long-term survival in locally advanced rectal cancer treated with preoperative chemoradiotherapy

    Journal of Oncology Pharmacy Practice, 2020

    DOI 10.1177/1078155219900944 PMID 32046577 7 citations (Europe PMC) Source : OpenAlex

  39. The predictive role of metabolic tumor volume on no response to neoadjuvant chemotherapy in patients with breast cancer

    Journal of Oncology Pharmacy Practice, 2020

    DOI 10.1177/1078155219898504 PMID 31955700 3 citations (Europe PMC) Source : OpenAlex

  40. The Effect of Obesity on Response to Neoadjuvant Therapy in Locally Advanced Gastric Cancer

    Asian Pacific Journal of Cancer Prevention, 2020

    DOI 10.31557/apjcp.2020.21.9.2723 PMID 32986374 4 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  41. Does the efficacy of regorafenib differ in chemotherapy refractory metastatic colorectal cancer patients who had mucinous pathology compared to those who had non-mucinous pathology?

    Current Problems in Cancer, 2020

    DOI 10.1016/j.currproblcancer.2020.100670 PMID 33129567 1 citation (Europe PMC) Source : OpenAlex

  42. The conversion of RAS status in metastatic colorectal cancer patients after first‐line biological agent treatment

    Colorectal Disease, 2020

    DOI 10.1111/codi.15389 PMID 33002301 3 citations (Europe PMC) Source : OpenAlex

  43. Combination of trastuzumab and taxane-containing intensified chemotherapy in first-line treatment of HER2-positive advanced gastric cancer

    Tumori Journal, 2020

    DOI 10.1177/0300891620969823 PMID 33167790 4 citations (Europe PMC) Source : OpenAlex

  44. The association of Visfatin levels with metabolic parameters and inflammation in diabetic nephropathy

    Eastern Journal Of Medicine, 2020

    DOI 10.5505/ejm.2020.27122 Source : OpenAlex

  45. The Real-Life Data of BRAF Mutation on the Treatment of Colorectal Cancer: a TOG Study

    Journal of Gastrointestinal Cancer, 2020

    DOI 10.1007/s12029-020-00514-9 PMID 32914373 4 citations (Europe PMC) Source : OpenAlex

  46. Factors affecting survival in operated pancreatic cancer; Does tumor localization have a significant effect on treatment outcomes?

    Northern Clinics of Istanbul, 2020

    DOI 10.14744/nci.2020.09735 PMID 33163885 2 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  47. Demographical and Clinical Features of Marginal Zone Lymphomas: A Retrospective Study of Turkish Oncology Group (TOG)

    Indian Journal of Hematology and Blood Transfusion, 2020

    DOI 10.1007/s12288-020-01257-0 PMID 33100705 1 citation (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  48. Does the Waiting Period for Genetic Tests Affect the Prognosis in Chemotherapy-Treated de novo Metastatic Non-Small Cell Lung Cancer Patients without a Driver Mutation?

    Oncology Research and Treatment, 2020

    DOI 10.1159/000511773 PMID 33242864 3 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  49. Recurrence of appendix tumor: case report and literature update

    The European Research Journal, 2020

    DOI 10.18621/eurj.594013 Texte intégral en libre accèsSource : OpenAlex

  50. Prognostic significance of basal 18F-FDG PET / CT maximum standardized uptake value in patients with metastatic renal cell carcinoma who were treated with sunitinib.

    PubMed, 2020

    PMID 33277873 Source : OpenAlex